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Biomimetic Block Copolymer Membranes
Katarzyna Kita-Tokarczyk and Wolfgang Meier*
Abstract: In this article, we review the recent advances in the field of block copolymer membranes. We discuss the
similarities and differences between natural membranes and their polymeric counterparts, pointing out the advan-
tages of the latter in applications for biosciences and biomaterials. Membrane properties are discussed in terms of
functionality and responsiveness, and the most interesting application possibilities are highlighted.
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task which is far from trivial. A cell mem-
brane is a uniquely complicated assembly of
lipids, sterols, sugars and proteins, and the
delicate balance and cooperation of these
components assures proper function. Such
a system is virtually impossible to repro-
duce in the laboratory, and even if it were,
it would not be scientifically too instructive,
as it would be difficult to assign particular
functions or processes to individual mem-
brane components.
On the other hand, certain membrane
structure details and many functions are
known. Models of lipid membranes have
been extensively studied, and information
is available on self-assembly principles
responsible for a bilayer formation,
[1–3]
in-
teractions between lipids,
[4]
sterols
[5]
and
membrane proteins.
[6]
Much interest has
been focused on membrane proteins, both
in the context of the self-assembly to func-
tion relationship, as well as structural de-
tails.
[7]
The above considerations also apply to
membranes from macromolecules, which,
although not encountered in nature, have
been shown to mimic biomembranes,
[8]
and
to outperform lipid bilayers in some cases.
[9]
As materials science has made enormous
progress recently, it is not surprising that
such membranes attract considerable atten-
tion. In this article, we will discuss proper-
ties of polymeric membranes and specific
applications that open a broader perspec-
tive for nanotechnology and biomedical
sciences.
2. Membrane Models
We will discuss membrane properties in
Section 4 so let us first briefly review the
experimentally available models. Mem-
brane models are always simplifications
of the living cell membranes, nevertheless,
they allow the discrimination of membrane-
related processes with respect to the build-
ing components.
One of the most frequently studied
self-organized structures from lipids, low
molecular-mass surfactants and macromo-
lecular amphiphiles are micelles, a very
rough approximation of a bilayer structure.
Spherical micelles are particularly conve-
nient for investigating solubilization of
hydrophobic molecules,
[10]
and may be rel-
evant for example when looking at micelle
diffusion by correlation spectroscopy after
a hydrophobic dye has been trapped within
the core.
[11]
They also find applications in
the delivery of hydrophobic drugs.
[12]
Ad-
ditionally, reports on successful protein
shielding by solubilization in micelles have
been published.
[13]
The disadvantage of a micellar structure
when studying membrane mimics is that
the ‘bilayer’ is not hydrated from two sides
– in this respect a vesicle comes closer to
what occurs in nature: in fact, lipid vesicles
do appear in cells. Owing to their structure,
vesicles can be applied as transport vehi-
cles for hydrophilic substances
[14]
or serve
as shielding capsules for delicate entities as
enzymes to protect them from the environ-
mental stress.
[15]
Liposomes (lipid vesicles)
are commercially used in pharmacy for de-
livery of toxic drugs such as chemothera-
peutics and antibiotics,
[16,17]
to minimize
side effects by slow release.
Apart from spherical models, planar
membranes attract much attention: zero
curvature is almost what is observed in
cells, a valid approximation if small mem-
brane areas are investigated. The disadvan-
tage is that planar membranes are in most
cases asymmetric: freely swimming lamel-
lae in solution are difficult to obtain, as they
would curve to closed spheres to minimize
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1. Introduction
Membranes are a ubiquitous building com-
ponent of living organisms. They separate
(compartmentalize) and protect cells and
cell organelles from their environment,
support their vital functions, such as water-,
ion- and nutrient transport, and maintain cell
integrity by the control of osmotic pressure
inside and outside the membrane-enclosed
space. Additionally, they are a platform for
electron- and proton transfer, essential for
cell metabolism. Even more, functions such
as cell transportation can be also related to
the presence of a membrane, as the flagel-
lum motor is entirely anchored to a double
lipid bilayer and so far has not been proven
to be active otherwise.
With these selected examples, it is not
surprising that the natural sciences are tak-
ing a closer look at membrane behavior; a
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the interfacial energy.
[18]
Apart from free-
standing ‘black lipid membranes’,
[19]
the
planar self-assemblies are either Langmuir
monolayers at the air-water interface,
[20]
or
supported films on solid substrates.
[4]
In
both cases, the environmental asymmetry
facilitates membrane formation. With pla-
nar membranes, it is possible, for example
to study component interactions, energetics
of protein insertion, influence of drugs or
amphiphile diffusion in two dimensions.
Solid supported membranes can also be
seen as a perspective platform for sensors
[21]
or templates for inorganics growth.
[22]
3. Membranes from Block
Copolymers
Membrane science includes various
aspects, from physical chemistry of self-
assembled systems, through biological and
pharmaceuticalapplications, tonanoscience
and membrane engineering. In our group,
the main interest is focused on membranes
formed from amphiphilic macromolecules,
and in particular from amphiphilic block
copolymers. Their underlying principles
are essentially the same as for natural mem-
branes, as are the stabilizing factors, such
as double layer electrostatics, steric interac-
tions or membrane curvature for vesicles.
On the other hand, the ‘macromolecular’
factors add an energetic contribution in the
form of strong hydration, and thus repul-
sion of large hydrophilic chains,
[23]
and ad-
ditionally the entropy of the hydrophobic
coil. Altogether, it can be argued that poly-
mer vesicles are actually thermodynamical-
ly stable structures,
[24,25]
whereas liposomes
are not.
[3]
When discussing polymer membranes
for biosciences, the first argument is the
membrane composition (chemistry). Poly-
mer membranes are built from synthetic
amphiphilic macromolecules, which auto-
matically bring at least two new parameters
to the membrane properties, uncommon to
lipid membranes. The first one is polydis-
persity, an intrinsic property of every poly-
mer sample. It may be seen unfavorable
when one wants to work with well-defined
systems, but on the other hand it adds the
possibility of chain segregation, especially
when species with non-matching thick-
nesses are inserted in the membrane.
[26]
Additionally, vesicle curvature is stabilized
by the segregation of shorter hydrophilic
chains towards the inside of the vesicle,
while longer chains will tend to point out-
wards (Fig. 1).
[27]
The second feature is flexibility of poly-
mer chains: compared to lipids, polymers
– due to their size – have many possibilities
of conformational arrangements when con-
fined to the membrane. In particular, dur-
ing compression of Langmuir monolayers,
broad transition plateaus are observed in
between defined two-dimensional phases,
owing to slow polymer dynamics and con-
formational rearrangements (Fig. 2).
[28]
In
consequence, we can obtain various packing
states; an advantage over lipid monolayers,
where only discrete states are available.
Polydispersityandflexibilitymakepoly-
mers unique membrane-forming materials,
however, for life sciences, biocompatibility
is essential. Introduction of a polymer into
a living organism may have unfavorable ef-
fects, but here chemistry turns out to be ac-
tually a very powerful tool. There are many
biocompatible polymers known, e.g. poly-
ethyleneoxide, polyesters, polypeptides,
[29]
and combinations of such blocks into am-
phiphilic molecules is possible. What is
more, we are able to choose between blocks
of different hydrophilic/hydrophobic prop-
erties and fluidity, to construct specific
polymers for particular needs. Contrary to
lipids, polymer chemistry permits various
chemical modifications to introduce func-
tionality and make polymers responsive to
environmental stimuli including pH, tem-
perature, ions, light, etc. On top of that,
thus obtained synthetic polymers form
membranes of excellent stability and long
shelf-life, where we do not encounter the
common problem of lipid oxidation leading
to liposome destabilization in solution.
Another important issueis themembrane
thickness: if membrane proteins are to be
inserted in such a self-assembled structure,
its thickness should be similar to that of lip-
id bilayers. In polymer systems, membrane
thickness depends on the polymer size and
the ratio between its hydrophilic and hy-
drophobic block(s),
[30]
dimensions from 3
up to 40 nm are achievable.
[31,32]
With re-
spect to the membrane protein insertion, it
was shown to be possible with membranes
thicker than a lipid bilayer, due to the fact
that shorter polymer chains would surround
the protein, and their flexibility allows the
Fig. 1. Chain packing in a planar and curved polymer membrane. Membrane
curvature is stabilized by segregation of long and short hydrophilic
chains.
Fig. 2. Surface pressure-mean molecular area isotherm from an ABA
triblock copolymer. Nomenclature of polymer phases from ref. [28].
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protein dimensions to be matched and the
hydrophobic interactions in the membrane
to be maximized.
[26]
4. Responsive Polymer Membranes
The self-assembly processes leading to
polymer membranes (vesicles) have been
reviewed,
[33–35]
and so were the character-
ization methods for polymersomes and
membrane characteristics.
[36]
Here, we will
focus on properties that make polymer
membranes extremely interesting with re-
spect to their possible applications.
In biosciences, responsiveness to exter-
nal stimuli is a crucial factor, especially in
drug release and construction of biomateri-
als. For example, poly(N-(3-aminopropyl)
methacrylamide hydrochloride)-block-(N-
isopropylacrylamide), a thermoresponsive
block copolymer, produces vesicles only
above a critical temperature.
[37]
The ag-
gregation to vesicles with a hydrodynamic
radius of ca. 150 nm is sharp and occurs
within 1–2 °C, while the transition tem-
perature itself can be adjusted by a block
size change. Polymers containing crystal-
line blocks, e.g. polyesters, can be forced
to produce vesicular membranes at higher
temperature: heating the sample leads to
the hydrophobic block melting, and then
amphiphilic segregation takes place to pro-
duce vesicles.
[38]
After the system is cooled
down, the aggregates are ‘trapped’ owing
to the membrane crystallinity, and remain
stable in solution.
Charged polymers are often exploited
to produce pH-sensitive membranes: here,
polypeptide blocks seem promising, espe-
cially those containing poly(glutamic acid)
or polylysine.
[39]
The hydrodynamic ra-
dius of polybutadiene-based vesicles with
poly(glutamic acid) corona was found to
depend on the pH and salt concentration in
solution.
[40]
The permeability and release
properties were not studied; however, as
the repulsion in corona blocks stabilizes
the vesicle curvature, one could expect pH-
dependent changes in long-term membrane
stability, which could promote this system
to a controlled release platform.
A family of propylene sulfide block
copolymers was found to build oxida-
tion responsive vesicles,
[41,42]
which can
be employed for drug delivery in sites of
increased oxidative stress, such as due to
inflammation. The possibility of controlled
disintegration of vesicles is a consequence
of the change in hydrophilic/hydrophobic
balance upon oxidation.
Tong et al.
[43]
reported light-responsive
vesicles from an azobenzene-based block
copolymer. These structures reversibly dis-
integrate when exposed to UV light (360
nm) due to conformational changes in the
azobenzene, which disturb the hydrophilic-
to-hydrophobic balance and thus the self-
assembly process. Interestingly, they can be
rebuilt after illumination with visible light
(440 nm). This is one of the few examples
of photosensitive membranes, the main dif-
ficulty here lying in the synthesis of the ap-
propriate polymers.
5. Polymer Membranes –
Applications
5.1. Therapeutic Applications
Almost every scientific report on
polymer vesicles nowadays will mention
‘drug delivery’ somewhere in the text. As
promising as it may sound, only a few real
drug delivery studies have emerged where
polymersomes were used.
[44,45]
A beautiful
example of a combined delivery platform
comes from Discher’s labs.
[46]
The authors
took on board the well-known and toxic
chemotherapeutic drugs, taxol and doxo-
rubicin. Both bring unpleasant side effects,
and therefore it was desirable to devise new
formulations to better control the drug re-
lease and minimize the undesired toxicity.
[47]
The concept involves using poly-ethylene-
oxide-poly-(lactic acid) block copolymer
vesicles, where doxorubicin is encapsulat-
ed in the hollow sphere, while taxol inserts
in the polymer membrane. Such two-in-one
formulations decreased the size of breast
cancer tumors in mice considerably and
performed better than free drugs.
In our group, poly(methyloxazoline)-
poly(dimethylsiloxane)-poly(methylox-
azoline) triblock amphiphilic copolymers
were used for drug targeting and delivery.
The targeting strategy
[48]
involved biotin–
streptavidin interactions:
[49]
biotinylated
polymers formed vesicles, next avidin was
added to attach to the outside of the vesi-
cles, and in the following step biotinylated
ligands, poly(guanylic acid) sequences,
were bound to the avidin’s free sites (Fig.
3).
The ligand was intended to specifi-
cally interact with a cell receptor, in this
case scavenger receptor A1, present in
macrophages responsible for cardiovascu-
lar disorders. Microscopy studies revealed
very good co-localization of receptors and
ligands, while no such effect was observed
with control cells, which did not possess the
A1 receptor.
The first step of bringing a nanocontain-
er to a place where it should release a drug
was successful, and the question of what
happens to the vesicles afterwards was ad-
dressed by Meier’s and Hunziker’s groups
in Basel.
[50]
The biotin–avidin platform de-
scribed above was used, but this time the
vesicles were loaded with a quenching con-
centration of calcein. Again, the vesicles
preferred to attach to macrophages and
showed no targeting of control cells. They
were observed to actually enter the cells,
most likely by endocytosis. After some
time, calcein was released, which could be
observed by fluorescence microscopy. The
mechanisms behind the cell entry and re-
lease processes are to be fully understood,
however, from the practical point of view
the platform offers the possibility to target
various cell receptors once appropriate li-
gands are attached to the vesicles. Another
aspect which needs to be considered here is
metabolism and accumulation of the used
polymers, which is unknown. Neverthe-
less, once the targeting platform is demon-
strated, even with a completely biologically
incompatible system, the concept can be
easily translated to different, biocompat-
ible polymers.
Another possibility for a therapeutic ap-
plication of polymer vesicles has been pre-
sented recently.
[51]
Superoxide dismutase,
an antioxidant enzyme, was encapsulated
in the vesicular cavity and shown to remain
Fig. 3. A schematic representation of a nanoreactor-based therapeutic
platform employing the biotin–avidin interactions
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functional in neutralizing superoxide radi-
cals in situ. The polymer membranes were
proven permeable to superoxide radicals by
pulse radiolysis, and the encapsulation of
the enzyme prolongs its lifetime, which is
only minutes in the bloodstream when non-
shielded.
The use of polymer vesicles as artifi-
cial oxygen carriers was demonstrated.
[52]
Compared to liposomes and PEG-ylated
liposomes, polymeric carriers had higher
capacity for encapsulation of hemoglobin,
and thus for oxygen binding. Another ad-
vantage of such an oxygen-delivery system
is that, unlike lipids, polymers did not in-
duce hemoglobin oxidation.
5.2. Nanoreactors
The use of proteins in combination with
polymers leads to a new class of biomate-
rials of potential use in nanotechnology as
nanoreactors, nanomachines etc., but also
in membrane engineering. Of the many
membrane proteins, the most interesting
are transporters (active and passive) and en-
zymes. It was shown that many membrane
proteins can be inserted in polymer mem-
branes and remain functional in such an ar-
tificial environment;
[53–55]
experimental data
being additionally supported by theoretical
considerations.
[26]
Two membrane proteins were used in
polymer vesicles for ATP production. In
this very sophisticated system, bacterior-
hodopsin inserted in the polymer mem-
branes pumped protons from the outside to
the inside of vesicles when illuminated by
light.
[56]
Next, these protons turned on the
ATP-ase, which had also been inserted in
the membrane, and when ADP was present,
ATP production could be monitored in solu-
tion.
[57]
The above demonstration of a nano-
machine can be viewed as a step towards
clean energy from protons and light, even if
it is a very far perspective from the practical
point of view due to its low efficiency in
its present form. From the academic point
of view, such platforms are excellent model
systems for the understanding of protein
function, as in the case of ATP-ase.
Different types of nanoreactors (Fig. 4)
were prepared using a bacterial pore, OmpF
(outer membrane protein F) as a channel for
substrates and product of enzymatic reac-
tions taking place within the vesicles.
[58,59]
Additionally, if the enzyme or the channel
protein is pH-dependent, switchable nano-
reactors can be produced by changing the
conditions in solution.
Cascade reactions in nanovesicles were
investigated by Vriezema et al.
[60]
A multi-
step reaction was sequentially catalyzed
by three enzymes: glucose oxidase encap-
sulated in vesicular cavities, horseradish
peroxidase inserted in polymer membranes
and Candida antarctica lipase B in the out-
side medium. The reaction turnover was de-
pendent on the positional assembly of the
enzymes; removal of any enzyme from the
system disturbed the cascade and no prod-
uct could be obtained.
5.3. Polymer Membranes
for Bio-mineralization
Bio-inorganics play an important role
not only in building teeth and bones, but
also find relatively exotic applications such
as in the magnetic ‘navigation’ systems of
some bacteria.
[61]
Templating bio-inorgan-
ics in vitro is motivated by two factors.
Firstly, medical applications are in focus:
we want to understand and hopefully mimic
the growth of bone minerals with the goal
of being able to construct bone replace-
ments. Not surprisingly, self-assembling
synthetic polymers are under investigation
as scaffolds, as their properties offer new
possibilities for controlled inorganic pro-
cessing.
[62]
On the other hand, we wish to take ad-
vantage of nature’s solutions and imple-
ment them in fields such as complex ma-
terials or medical imaging. As an example,
the aforementioned magnetic particles
found in bacteria to navigate them against
the Earth’s magnetic field, also find appli-
cations in medical imaging for detection of
liver cancer.
[63]
Many studies on calcium phosphate
concentrate on templating the growth of
this inorganic by various scaffolds.
[64]
Many
particle morphologies can be obtained, de-
pending on the growth conditions and the
scaffold chemistry.
[65]
The understanding of
how the particle growth can be optimized
is crucial when we do not have at hand all
the regulatory mechanisms present in living
cells/organisms. So far, many polymeric
scaffolds were used for inorganic templat-
ing,
[66]
and very interesting shapes were
obtained.
[67]
Polymer vesicles were used to achieve
spatial control over the mineralization pro-
cess.
[68]
Alamethicin, an ion channel peptide
inserted in a vesicle membrane, enabled
cation (calcium) transport, when phosphate
buffer was present inside the vesicles. After
a certain incubation time, calcium phos-
phate crystals were seen inside the vesicles,
while no crystallization occurred in the out-
side medium.
Planar polymer films were recently
mineralized with calcium phosphate.
[65]
By application of the Langmuir monolayer
technique, we managed to control the par-
ticle growth by manipulating the polymer
film properties at the air–water interface,
i.e. surface pressure, or the degree of pack-
ing in two dimensions, and the subphase
parameters such as pH and ion strength.
With small changes in the growth condi-
tions, we achieved various particle shapes
and dimensions: such results are indeed
very motivating for further studies towards
other templated inorganics using synthetic
polymers.
5.4. Planar Polymer Membranes
Planar polymer films, either free-stand-
ing or at interfaces, are of particular inter-
est; not only are they preferred in many
applications, but also allow surface studies
which could not be performed on vesicles.
Therefore, by combining the investigations
of vesicles with those on planar membranes
we achieve a more complete picture of
membrane self assembly. We have men-
tioned Langmuir film mineralization, and
would like to highlight here other advan-
tages of planar membranes.
Langmuir monolayers from a vesicle-
forming amphiphilic triblock copolymer
were studied to aid understanding of the
polymer interactions with a cation trans-
porting peptide, alamethicin.
[28]
In lipid bi-
layers, this amphiphilic helical peptide ag-
gregates to form channels,
[69]
and thus alters
the bilayer properties. Since we found the
peptide functional also in polymeric mem-
branes,
[68]
thermodynamics of interactions
in such a composite system was studied,
and the results revealed that as long as the
aggregation state may be postulated to be
similar in both lipid and polymer environ-
ments, as visualized by Brewster angle mi-
croscopy, the excess mixing energy is lower
in polymer films.
[28]
Interestingly, longer
polymers tend to minimize this energy even
more. Those results mean that energetically
the peptide prefers to be present in films
from synthetic polymers, and are explained
Fig. 4. A schematic representation of a nanoreactor
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by conformational freedom of the soft poly-
mer compared to the relatively rigid lipid
molecules, allowing for the optimum pack-
ing of the polymer chains in the immediate
surrounding of the peptide channels. This
fact explains again why many membrane
proteins remain functional in polymeric
membranes.
Another very interesting aspect was the
investigation of the 2D mechanical proper-
ties of polymer–peptide films: apparently,
by appropriate proportion of the two com-
ponents the film rigidity and compressibil-
ity can be fine-tuned and phases with new
properties can be obtained. This fact is of
fundamental importance in hybrid mate-
rial science, where novel features are often
sought by a combination of synthetic poly-
mers with biologically active molecules.
In environmental engineering, a crucial
problem is the supply of drinking water,
which is often produced from sea water by
osmosis using desalination membranes.
[70]
For this purpose, polymer membranes with
embedded water transporting proteins,
aquaporins, could be used (Fig. 5).
Fig. 5. A scheme of a protein-reconstituted
polymer membrane
It was recently demonstrated that per-
meability of polymer–protein membranes
are at least an order of magnitude higher
than what can be achieved by commercial
desalination membranes.
[71]
This effect
is only observed when aquaporin is used;
purely polymeric vesicles have very poor
water permeability.
Planar solid-supported block copolymer
membranes would not only be interesting
for engineering applications, but also for
protein insertion in order to study membrane
transport or diffusion. So far, concerning
organized amphiphilic membranes on solid
surfaces, grafted films were produced from
poly(butyl methacrylate)-co-poly(2,2-di-
methylaminoethyl methacrylate).
[72]
Using
the same positively charged polymer, the
first planar solid-supported block copoly-
mer films were achieved by vesicle fusion
on negatively charged surfaces like mica
and silicon oxide.
[73]
On the other hand, it
was shown that tethered lipid membranes
can functionally accommodate membrane
proteins.
[74]
Even though the exact proto-
cols from physical chemistry of lipids can-
not be always translated to polymers, the
concept itself could be employed for appli-
cations such as sensor development, given
the stability and robustness of the polymer
self-organized film. The sensed molecules
could be either odorant species, or physi-
ologically relevant ligands.
6. Summary
In summary, we have presented an
overview of recent scientific activities in
the field of polymer membranes. Whether
spherical or planar, they turn out to be ex-
cellently suited as biomembrane mimics
and enable basic studies and applications
at the nanoscale. Self-assembly processes
governing the membrane formation can be
taken advantage of in order to create sub-
micrometer structures by subtle changes
in parameters such as polymer size, block
ratio, polydispersity etc. Experimental
conditions, such as solvent addition, pH
and temperature also influence the result-
ing structures. These factors combined
together allow to engineer systems for
chemical reactions at the nanoscale, thera-
peutic applications or inorganic templat-
ing.
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